Eye-Tracking Rapid Attention Computation (Eye-TRAC)

This study has been completed.
Sponsor:
Collaborator:
Information provided by (Responsible Party):
Jamshid Ghajar, M.D., Ph.D., Brain Trauma Foundation
ClinicalTrials.gov Identifier:
NCT00743821
First received: August 28, 2008
Last updated: May 5, 2014
Last verified: May 2014
  Purpose

The purpose of this study is to validate and refine a diagnostic device that can detect attention and memory deficits that result from mild traumatic brain injury (mTBI).


Condition
Post Concussive Syndrome, Chronic

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional
Official Title: Eye-Tracking Rapid Attention Computation

Resource links provided by NLM:


Further study details as provided by Brain Trauma Foundation:

Enrollment: 426
Study Start Date: October 2008
Study Completion Date: September 2012
Primary Completion Date: September 2012 (Final data collection date for primary outcome measure)
Groups/Cohorts
TBI Patients
Individuals who have suffered a mild traumatic brain injury and have persistent post-concussive symptoms (PCS)
Normals
Individuals of comparable age and education who have not suffered a traumatic brain injury

Detailed Description:

The main goal of this project is the development of a military-ready, sensitive and rapid eye tracking diagnostic device for individuals with mild traumatic brain injury (mTBI). The device will also be tested for its efficacy in diagnosing fatigue and identifying aging effects. We will use a predictive visual tracking paradigm to dynamically capture the attentional state and correlate the subject's performance with the degree of disruption in the attention network caused by mTBI, aging and fatigue. The device will be tested for its diagnostic capabilities based on its selectivity, reliability, sensitivity and validity for individuals of varying ages (with and without mTBI) and in military personnel who have undergone 26 hours of sleep deprivation.

Testing will be conducted at two sites:

  1. Civilians with mTBI; and civilians with adult attention deficit hyperactivity disorder will be tested by trained staff of the Brain Trauma Foundation (BTF) at Weill Cornell Medical College (WCMC) in New York City. The ages of the enrolled individuals will range between 18-55 years in order to examine aging effects.
  2. Enrolled service members will be tested at the United States Army Research Institute of Environmental Medicine (USARIEM) in Natick, Massachusetts. These service members will be healthy volunteers without a history of mTBI. Some of these subjects will undergo 26 hours of sleep deprivation during which they will be tested at specific time points.

Our objectives are:

1. Prove that the eye-tracking concept can be brought from a successful laboratory device to a specific, reliable, selective, and valid diagnostic tool.

1.1. Test reliability by examining the test-retest reliability measures of EYE-TRAC;

1.2. Test selectivity by testing the ability to differentiating the effects of fatigue, aging, and mTBI on EYE-TRAC measures;

1.3. Test validity by determining the relationship between measures of attention and working memory based on the EYE-TRAC and validated measures of sustained attention and working memory;

1.4. Test specificity by measuring the spectrum of TBI injury using MRI-DTI and correlate with EYE-TRAC.

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

TBI patients will be recruited from an outpatient TBI clinic Normals will be friends/family of TBI patients who have not suffered a TBI, as well as individuals recruited from the community

Criteria

Normals:

Inclusion Criteria:

  • Healthy volunteer
  • Education up to 12th grade

Exclusion Criteria:

  • History of concussion or TBI
  • Alcohol or substance abuse problems, neurological disorders, major psychiatric disorders (including ADHD or PTSD)
  • Gross visual or hearing problems
  • Pregnancy
  • Metal in the body or any contraindications for MRI

TBI Patients:

Inclusion Criteria:

  • Education up to 12th grade
  • Persistent post concussive symptoms after an isolated incident of head injury with or without loss of consciousness between 3 months to 5 years prior to participation

Exclusion Criteria

  • Prior history of seizures
  • Pregnant woman
  • Alcohol or substance abuse problems, neurological disorders, major psychiatric disorders (including ADHD or PTSD)
  • Gross visual or hearing problems
  • Any metal in the body or contraindications for MRI
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00743821

Locations
United States, New York
Citigroup Imaging Center, Weill Medical College of Cornell University
New York, New York, United States, 10021
Sponsors and Collaborators
Brain Trauma Foundation
Investigators
Principal Investigator: Jamshid Ghajar, M.D., Ph.D. Brain Trauma Foundation
  More Information

No publications provided

Responsible Party: Jamshid Ghajar, M.D., Ph.D., President, Brain Trauma Foundation
ClinicalTrials.gov Identifier: NCT00743821     History of Changes
Other Study ID Numbers: PT075553, IRB Protocol #0211005884
Study First Received: August 28, 2008
Last Updated: May 5, 2014
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Post-Concussion Syndrome
Brain Concussion
Brain Injuries
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Craniocerebral Trauma
Trauma, Nervous System
Head Injuries, Closed
Wounds and Injuries
Wounds, Nonpenetrating

ClinicalTrials.gov processed this record on September 11, 2014